FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

47111000052106: Enzyme replacement therapy in lysosomal alpha-1,4-glucosidase deficiency - infantile onset (Pompe disease) (procedure)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-May 2015. Module: SNOMED CT Sweden NRC maintained module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module
3744881000052110 Enzyme replacement therapy in lysosomal alpha-1,4-glucosidase deficiency - infantile onset (Pompe disease) (procedure) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT Sweden NRC maintained module (core metadata concept)
3744891000052112 Enzyme replacement therapy in lysosomal alpha-1,4-glucosidase deficiency - infantile onset (Pompe disease) en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT Sweden NRC maintained module (core metadata concept)
3744901000052113 enzymersättningsbehandling vid Pompes sjukdom sv Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT Sweden NRC maintained module (core metadata concept)


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Enzyme replacement therapy in lysosomal alpha-1,4-glucosidase deficiency - infantile onset (Pompe disease) (procedure) Is a åtgärd med fokus på specifikt kliniskt fynd false Inferred relationship Some
Enzyme replacement therapy in lysosomal alpha-1,4-glucosidase deficiency - infantile onset (Pompe disease) (procedure) Is a Drug therapy (procedure) true Inferred relationship Some
Enzyme replacement therapy in lysosomal alpha-1,4-glucosidase deficiency - infantile onset (Pompe disease) (procedure) Has focus brist på lysosomal alfa-1,4-glukosidas, infantil debut false Inferred relationship Some
Enzyme replacement therapy in lysosomal alpha-1,4-glucosidase deficiency - infantile onset (Pompe disease) (procedure) Direct substance enzymläkemedel false Inferred relationship Some 3
Enzyme replacement therapy in lysosomal alpha-1,4-glucosidase deficiency - infantile onset (Pompe disease) (procedure) Has intent Therapeutic true Inferred relationship Some 4
Enzyme replacement therapy in lysosomal alpha-1,4-glucosidase deficiency - infantile onset (Pompe disease) (procedure) Method Administration - action true Inferred relationship Some 1
Enzyme replacement therapy in lysosomal alpha-1,4-glucosidase deficiency - infantile onset (Pompe disease) (procedure) Direct substance Drug or medicament (substance) true Inferred relationship Some 1
Enzyme replacement therapy in lysosomal alpha-1,4-glucosidase deficiency - infantile onset (Pompe disease) (procedure) Has focus Glycogen storage disease due to acid maltase deficiency true Inferred relationship Some 2
Enzyme replacement therapy in lysosomal alpha-1,4-glucosidase deficiency - infantile onset (Pompe disease) (procedure) Direct substance Enzyme true Inferred relationship Some 3

Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start